Avalo Therapeutics Announces Key Developments and Financial Overview for Q1 2025
May 12, 2025 - 14:37
Mike Heffernan has been appointed as the new Chairman of the Board at Avalo Therapeutics, marking a significant leadership change for the company. In addition to this appointment, the company is anticipating the release of topline data from its Phase 2 LOTUS trial for AVTX-009, a treatment aimed at addressing hidradenitis suppurativa, with results expected in 2026.
As of March 31, 2025, Avalo reported a robust cash position of approximately $125 million, which is projected to provide sufficient financial runway into 2027. This funding will allow the company to continue its focus on developing innovative therapies for immune dysregulation, with the potential to extend operations into 2028 if necessary.
These updates reflect Avalo's commitment to advancing its clinical programs and enhancing shareholder value as it navigates the complexities of the biotechnology landscape. The leadership transition and solid financial standing position the company for future growth and success in the coming years.
MORE NEWS
August 21, 2026 - 03:11
Ballet Student Jessica Wang Makes Tiaras Her BusinessFor most ballet students, the focus is on perfecting a pirouette or landing a role in the spring showcase. For Jessica Wang, the real challenge came offstage: building a small business that makes...
August 20, 2026 - 13:00
Baldwin Park business trying to pivot after leak leaves them closedA sudden pipe leak has forced Lafayette & Rushford, a home decor store in Baldwin Park, to close its doors indefinitely. The damage from the water is significant, and the owners say they have no...
August 19, 2026 - 21:02
How Small Businesses Can Save 10% on the Supplies They Need to SucceedRunning a small business means watching every dollar, especially when it comes to routine purchases like office paper, cleaning products, or shipping boxes. These expenses add up quickly, but there...
August 19, 2026 - 04:32
Scott Seaman Selected to Crain’s Chicago Business 2026 Notable Leaders in Accounting, Consulting & LawHinshaw & Culbertson LLP has announced that Scott Seaman, a partner and co-chair of the firm`s global Insurance Services group, has been recognized by Crain`s Chicago Business as a 2026 Notable...